PUBLISHER: TechNavio | PRODUCT CODE: 1937467
PUBLISHER: TechNavio | PRODUCT CODE: 1937467
Global Oligonucleotide Synthesis Market 2026-2030
The global oligonucleotide synthesis market is forecasted to grow by USD 5593.6 mn during 2025-2030, accelerating at a CAGR of 17.8% during the forecast period. The report on the global oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in oligonucleotide synthesis methods, escalating demand for oligonucleotide-based therapeutics, surging investments and strategic collaborations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 15.3% |
| CAGR | 17.8% |
| Incremental Value | $5593.6 mn |
Technavio's global oligonucleotide synthesis market is segmented as below:
By Application
- PCR primers
- PCR assays and panels
- DNA microarrays
- Fluorescence in situ hybridization
- Others
By End-User
- Pharmaceutical and biotechnology companies
- Research and academic institutes
- Diagnostic laboratories
- Hospitals
By Product
- Oligonucleotide products
- Reagents and consumables
- Synthesis equipment
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the shift toward enzymatic and sustainable synthesis methods as one of the prime reasons driving the global oligonucleotide synthesis market growth during the next few years. Also, expansion of oligonucleotide applications in therapeutics and precision medicine and increasing adoption of high-throughput and automated synthesis platforms will lead to sizable demand in the market.
The report on the global oligonucleotide synthesis market covers the following areas:
- Global oligonucleotide synthesis market sizing
- Global oligonucleotide synthesis market forecast
- Global oligonucleotide synthesis market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Bio Pharma Services, Ansa Biotechnologies, Azenta Inc., Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., GenScript Biotech Corp., Kaneka Corp., LGC Ltd., Merck KGaA, Nitto Denko Corp., QIAGEN N.V., Synbio Technologies LLC, Syngene International Ltd., Thermo Fisher Scientific Inc., Twist Bioscience Corp., WuXi AppTec Co. Ltd.. Also, the global oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Oligonucleotide Synthesis Market 2020 - 2024
- Historic Market Size - Data Table on Global Oligonucleotide Synthesis Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Oligonucleotide Synthesis Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 PCR primers - Market size and forecast 2025-2030
- 8.4 PCR assays and panels - Market size and forecast 2025-2030
- 8.5 DNA microarrays - Market size and forecast 2025-2030
- 8.6 Fluorescence in situ hybridization - Market size and forecast 2025-2030
- 8.7 Others - Market size and forecast 2025-2030
- 8.8 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
- 9.4 Research and academic institutes - Market size and forecast 2025-2030
- 9.5 Diagnostic laboratories - Market size and forecast 2025-2030
- 9.6 Hospitals - Market size and forecast 2025-2030
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Product
- 10.1 Market segments
- 10.2 Comparison by Product
- 10.3 Oligonucleotide products - Market size and forecast 2025-2030
- 10.4 Reagents and consumables - Market size and forecast 2025-2030
- 10.5 Synthesis equipment - Market size and forecast 2025-2030
- 10.6 Market opportunity by Product
- Market opportunity by Product ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 UAE - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 Israel - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.6.7 Argentina - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Technological advancements in oligonucleotide synthesis methods
- Escalating demand for oligonucleotide-based therapeutics
- Surging investments and strategic collaborations
- 13.2 Market challenges
- High manufacturing costs and scalability limitations
- Stringent regulatory requirements and compliance hurdles
- Complexities in large-scale production and supply chain vulnerabilities
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Shift toward enzymatic and sustainable synthesis methods
- Expansion of oligonucleotide applications in therapeutics and precision medicine
- Increasing adoption of high-throughput and automated synthesis platforms
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.5 Ajinomoto Bio Pharma Services
- Ajinomoto Bio Pharma Services - Overview
- Ajinomoto Bio Pharma Services - Product / Service
- Ajinomoto Bio Pharma Services - Key offerings
- SWOT
- 15.6 Ansa Biotechnologies
- Ansa Biotechnologies - Overview
- Ansa Biotechnologies - Product / Service
- Ansa Biotechnologies - Key offerings
- SWOT
- 15.7 Azenta Inc.
- Azenta Inc. - Overview
- Azenta Inc. - Business segments
- Azenta Inc. - Key news
- Azenta Inc. - Key offerings
- Azenta Inc. - Segment focus
- SWOT
- 15.8 Bio Synthesis Inc
- Bio Synthesis Inc - Overview
- Bio Synthesis Inc - Product / Service
- Bio Synthesis Inc - Key offerings
- SWOT
- 15.9 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings
- SWOT
- 15.10 Biotage AB
- Biotage AB - Overview
- Biotage AB - Product / Service
- Biotage AB - Key offerings
- SWOT
- 15.11 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 15.12 GenScript Biotech Corp.
- GenScript Biotech Corp. - Overview
- GenScript Biotech Corp. - Business segments
- GenScript Biotech Corp. - Key offerings
- GenScript Biotech Corp. - Segment focus
- SWOT
- 15.13 Kaneka Corp.
- Kaneka Corp. - Overview
- Kaneka Corp. - Business segments
- Kaneka Corp. - Key news
- Kaneka Corp. - Key offerings
- Kaneka Corp. - Segment focus
- SWOT
- 15.14 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.15 Nitto Denko Corp.
- Nitto Denko Corp. - Overview
- Nitto Denko Corp. - Business segments
- Nitto Denko Corp. - Key offerings
- Nitto Denko Corp. - Segment focus
- SWOT
- 15.16 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
- 15.17 Synbio Technologies LLC
- Synbio Technologies LLC - Overview
- Synbio Technologies LLC - Product / Service
- Synbio Technologies LLC - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
